Intel-GE partnership to study telehealth in senior living care

Intel-GE Care Innovations, a joint venture between Intel Corporation and GE Healthcare, has partnered with Front Porch communities and the Front Porch Center for Innovation and Wellbeing to measure the benefits of leveraging remote patient monitoring (RPM) with senior living residents. 

Residents of Kingsley Manor in Los Angeles and Claremont Manor in Claremont, California, will use Health Harmony, Care Innovations’ RPM platform that simplifies RPM by providing intuitive and technology that enables individuals, clinicians, care providers and family caregivers to collaborate for better care in the home and within normal daily routines. Initially, Health Harmony will be available to a group of Front Porch residents who may require a higher level of care and monitoring due to poor chronic condition management or following a return to a senior living community after a discharge from a skilled nursing facility.

Residents who use Health Harmony will conduct daily health sessions to capture vital signs such as blood pressure, weight, oxygen levels and glucose levels, subjective health assessments and other information needed for caregivers to manage care plans, promote medication adherence and remain on top of patients’ changing health. Residents also have access to a video chat platform through Health Harmony that enables a caregiver and the resident to virtually connect with one another to discuss conditions and assess a resident’s environment.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.